The pharmaceutical industry is at risk from Brexit | LSE BREXIT

The pharmaceutical industry is at risk from Brexit | LSE BREXIT: The pharmaceutical industry is at risk from Brexit. Border delays, R&D disruption and regulatory divergence pose hazards to this important industry, writes Jianwei Xu. Despite numerous debates …

explicita